Sio Capital Management, LLC Vertex Pharmaceuticals Inc Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $4.51 Million - $5.7 Million	-25,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $290,224 - $324,784	1,600 Added 6.69%	25,500 $4.63 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $531,159 - $626,376	2,833 Added 13.45%	23,900 $4.82 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $1.06 Million - $1.24 Million	-5,133 Reduced 19.59%	21,067 $4.53 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $5.42 Million - $7.23 Million	26,200 New	26,200 $6.19 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $4.69 Million - $5.28 Million	-28,232 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $4.62 Million - $5.5 Million	28,232 New	28,232 $5.19 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $2.25 Million - $2.63 Million	-14,874 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $2.2 Million - $2.41 Million	14,874	14,874 $2.26 Million

1,721

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.